Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
| Weiss Ratings | DTXMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | DTXMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | DTXMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -13.45 | |||
| Price History | DTXMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.04% | |||
| 30-Day Total Return | 3,074.67% | |||
| 60-Day Total Return | 3,074.67% | |||
| 90-Day Total Return | 3,074.67% | |||
| Year to Date Total Return | 3,074.67% | |||
| 1-Year Total Return | 7,226.15% | |||
| 2-Year Total Return | 1,090.50% | |||
| 3-Year Total Return | 153.97% | |||
| 5-Year Total Return | 217.47% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 7,226.15% | |||
| Price | DTXMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.10 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Apr 03, 2024 | |||
| 52-Week High Price (Date) | Feb 05, 2025 | |||
| Valuation | DTXMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 180.58M | |||
| Enterprise Value | 182.49M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -44.44% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 86.58 | |||
| Price/Book (Q) | 50.13 | |||
| Enterprise Value/Revenue (TTM) | 81.29 | |||
| Price | $0.10 | |||
| Enterprise Value/EBITDA (TTM) | -223.03 | |||
| Enterprise Value/EBIT | -203.58 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | DTXMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.89B | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | DTXMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 44 12 4377 4837 | |||
| Address | -- | |||
| Website | www.deltexmedical.com | |||
| Country | United Kingdom | |||
| Year Founded | 2000 | |||
| Profitability | DTXMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -39.93% | |||
| Profit Margin | -72.38% | |||
| Management Effectiveness | DTXMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -7.73% | |||
| Return on Equity | -- | |||
| Income Statement | DTXMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 2.24M | |||
| Total Revenue (TTM) | 2.24M | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 1.40M | |||
| EBITDA (TTM) | -818.20K | |||
| EBIT (TTM) | -896.40K | |||
| Net Income (TTM) | -1.62M | |||
| Net Income Avl. to Common (TTM) | -1.62M | |||
| Total Revenue Growth (Q YOY) | 1.25% | |||
| Earnings Growth (Q YOY) | -2.47% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 60.00% | |||
| Balance Sheet | DTXMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 412.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 1.82M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 3.40M | |||
| Current Ratio (Q) | 0.890 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 6.95M | |||
| Total Current Liabilities (Q) | 2.04M | |||
| Total Debt (Q) | 2.51M | |||
| Total Liabilities (Q) | 3.55M | |||
| Total Common Equity (Q) | 3.58M | |||
| Cash Flow | DTXMF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -157.90K | |||
| Cash from Financing (TTM) | 2.06M | |||
| Net Change in Cash (TTM) | 270.60K | |||
| Levered Free Cash Flow (TTM) | -1.44M | |||
| Cash from Operations (TTM) | -1.67M | |||
